---
title: "復星醫藥獲得 60 億元債券發行的監管批准"
description: "復星醫藥獲得監管批准發行 60 億元債券"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/277044151.md"
published_at: "2026-02-26T12:51:40.000Z"
---

# 復星醫藥獲得 60 億元債券發行的監管批准

> 復星醫藥獲得監管批准發行 60 億元債券

### Related Stocks

- [02196.HK - 復星醫藥](https://longbridge.com/zh-HK/quote/02196.HK.md)
- [600196.CN - 復星醫藥](https://longbridge.com/zh-HK/quote/600196.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Shanghai Fosun Pharmaceutical erhält Annahme für Arzneimittelzulassungsantrag | Shanghai Fosun Pharmaceutical (Group) Co. Ltd. announced that a subsidiary's drug approval application has been accepted | [Link](https://longbridge.com/zh-HK/news/275434480.md) |
| Fosun Pharma Unit Gets China Acceptance for Anesthesia Drug Application | Fosun Pharma Unit Gets China Acceptance for Anesthesia Drug Application | [Link](https://longbridge.com/zh-HK/news/275893661.md) |
| Fosun Pharma Reports Strong Shareholder Turnout at 2026 Extraordinary Meetings | Shanghai Fosun Pharmaceutical (Group) Co. reported strong shareholder turnout at its 2026 extraordinary general meetings | [Link](https://longbridge.com/zh-HK/news/277222806.md) |
| Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China | Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China | [Link](https://longbridge.com/zh-HK/news/276886600.md) |
| Fosun Pharma Seeks Approval for New Indication of Cancer Drug | Fosun Pharma Seeks Approval for New Indication of Cancer Drug | [Link](https://longbridge.com/zh-HK/news/269679647.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。